Citation:Jankowski J, Moayyedi P 2004

From Cancer Guidelines Wiki


Jankowski J, Moayyedi P. Re: Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus. J Natl Cancer Inst 2004 Jun 2;96(11):885-7; author reply 887 Abstract available at

Critical appraisals

Compare quality appraisals for each clinical question

Cited by

  1. What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?